Varsha Bhakta
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Corrigendum to "Substitution of reactive centre loop residues from C1 esterase inhibitor increases the inhibitory specificity of alpha-1 antitrypsin for plasma kallikrein" [J. Biotechnol. 405 (2025) 205-214].
Journal: Journal of biotechnology
Published: November 09, 2025
Expression and purification of a broad-spectrum human protease inhibitor in Pichia pastoris.
Journal: Biochemistry and biophysics reports
Published: March 10, 2025
Substitution of reactive centre loop residues from C1 esterase inhibitor increases the inhibitory specificity of alpha-1 antitrypsin for plasma kallikrein.
Journal: Journal of biotechnology
Published: February 04, 2025
Extension of the circulatory half-life of recombinant ecallantide via albumin fusion without loss of anti-kallikrein activity.
Journal: Journal of biotechnology
Published: March 18, 2024
Prolonging the circulatory half-life of C1 esterase inhibitor via albumin fusion.
Journal: PloS one
Published: March 14, 2024
Spotlight on animal models of acute traumatic coagulopathy: an update.
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: March 14, 2022
Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing.
Journal: Transfusion
Published: February 03, 2022
Retention of hemostatic and immunological properties of frozen plasma and COVID-19 convalescent apheresis fresh-frozen plasma produced and freeze-dried in Canada.
Journal: Transfusion
Published: July 29, 2021
Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant.
Journal: Frontiers in cardiovascular medicine
Published: December 29, 2020
Last Updated: 09/26/2026